Return to The AAPP Perspective issue main page.< Previous Article

New Case Series

  

CPNP has launched a case series featuring patient cases of varying complexity. These cases offer a comprehensive learning experience in psychiatric pharmacotherapy and include a referenced answer key. Four cases to date focus on first-line therapies while four additional feature more complex cases focused on second and third-line therapies. Experience a first line depression case compliments of CPNP and purchase others for the low fee of $15 each at CPNP University.

"New" Psychotropics: New Chemical Entities and New Dosage Forms

  

The Mental Health Clinician is a monthly open access publication of interest to any health care professional working with neuropsychiatric pharmacotherapy. The January issue of the MHC focuses on the clinically relevant similarities and differences between newly approved psychotropics and similar older agents. Extended release products, single isomers, prodrugs, active metabolites and other formulations are discussed.

Only 3 Weeks Remain to Register for CPNP 2014 at Early Bird Rates

  

The CPNP 2014 Annual Meeting will be held in Phoenix, Arizona, on April 27-30, 2014. CPNP's Annual Meeting is regarded as the premier conference on neuropsychiatric pharmacy. With over 500 attendees and popular features like learning labs and community gatherings, there is a chance for everyone to connect with other mental health professionals. The combination of high-level ACPE programming, BCPP recertification programming, and student programming ensures that there is rich content for every practitioner. Read more about the annual meeting and register online.

The Pharmacist's Role in Paving the Treatment Success Pathway for Schizophrenia

  

CPNP and RMEI are pleased to bring you two complimentary, self-study online courses. In The Pharmacist's Role in Paving the Treatment Success Pathway for Schizophrenia, participants learn to differentiate safety, efficacy, pharmacokinetics (PK), and adherence data for the agents used in the long-term maintenance of schizophrenia. Focus is placed on healthcare decision-making and motivation among schizophrenia patients and case scenarios allow for the performance of interventions that improve access to and use of antipsychotic medications, include LAIs. In the Patient Follow-Up Activity, have the opportunity to dig in deeper and apply information learned to several more patient cases.

2014 BCPP Recertification and Preparatory Products Now Available

  

Designed for the dual purpose of BCPP examination preparation and BCPP recertification, the Psychiatric Pharmacotherapy Review Course has become increasingly valued as a quality reference source. Released February 3, this course has many new features for 2014:

  • Given its value as a reference source and as an educational program for healthcare professionals beyond pharmacy, this course has been retitled to Psychiatric Pharmacotherapy Review Course from the previous title of BCPP Examination Review and Recertification Course.
  • ACCME credit is now available for the course.
  • Modules from the course are available for individual sale in CPNP University (search on Psychiatric Pharmacotherapy Review Course). Those accessing the course for Recertification credit still purchase the course as the full 20 hour course at https://aapp.org/bcpp/recertification/registration.

 

Return to The AAPP Perspective issue main page.< Previous Article
25 Years!